Up to 31% off peptides
ORP-2(TR) 30mg research vial

ORP‑2(TR)

For laboratory research. Sold in 30mg, 30mg x 2 and 300mg kit sizes.

$103.50
$15031% off
In stock2-Day Priority Air anywhere in the US
Choose your size
Savings per mg compared with the 30mg size.
1
Secure checkout2-Day Priority AirThird-party tested

Complete the order

Frequently bought together

Supplies and compounds researchers add to this order

Finding add-ons…
Shipping & returns
  • 2-Day Priority Air: $13 flat anywhere in the US, or pick up in Medford.
  • Tracking is emailed the moment your order ships.
  • Research compounds are final sale; see the refund policy.
Lab sheet

ORP-2(TR), measured

Identity, purity and handling data for this compound, in one place. Tap an identifier to copy it.

Certificate of analysis
99.61%
HPLC purity, 30mg lot, reported 04/29/2026
Tested by Freedom Diagnostics, an independent lab. Search code Opti2604280004
View the certificate
Molar Mass
Approx. 4813.5 Da
CAS Number
2023788-19-2
Form
Lyophilized powder
Full data sheet+
Purity
See the available batch report for the tested sample's purity. Confirm the product and lot before ordering.

For research use only. Not for human consumption.

Overview

About ORP-2(TR)

ORP-2(TR) is a synthetic 39-amino acid peptide that functions as a dual agonist at the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR). Its design incorporates a fatty diacid moiety via a linker at lysine-26 to enable albumin binding and extend the half-life to approximately five days, supporting once-weekly administration in clinical study protocols.

Read more

The dual incretin mechanism of ORP-2(TR) has attracted broad research interest because GIP and GLP-1 receptors are co-expressed in key metabolic tissues including pancreatic islets, adipose tissue, and the central nervous system. Preclinical and clinical research has investigated how simultaneous agonism of both receptors influences insulin secretion, glucagon suppression, gastric emptying, adipogenesis, and body weight regulation differently from selective GLP-1 receptor agonists.

As a research compound, ORP-2(TR) is studied to better understand the biology of the incretin system and the metabolic consequences of dual GIPR/GLP-1R engagement. It is provided for laboratory research use only and is not supplied for therapeutic administration outside of formally regulated clinical contexts.

Research context

What ORP-2(TR) is researched for

The areas where this compound appears in the published research literature.

0105 areas

Dual incretin receptor pharmacology

ORP-2(TR) is used in GLP-1R and GIPR transfected cell lines to investigate how simultaneous dual receptor agonism differs from monoagonism in cAMP production, beta-arrestin recruitment, and receptor internalization profiles.

0205 areas

Pancreatic beta-cell biology

Research in islet and beta-cell models has examined how ORP-2(TR) influences glucose-stimulated insulin secretion, beta-cell proliferation markers, and glucotoxicity protection compared to selective GLP-1R agonists.

0305 areas

Adipose tissue and lipid metabolism research

GIPR is highly expressed in adipose tissue. Studies have investigated how ORP-2(TR) influences adipocyte differentiation, lipolysis signaling, and lipid storage gene expression in fat cell models.

0405 areas

Central nervous system appetite signaling

Both GLP-1R and GIPR are expressed in hypothalamic and brainstem nuclei. Research has explored how ORP-2(TR) affects neuronal activity, neuropeptide expression, and energy balance-related gene programs in CNS cell and animal models.

0505 areas

Comparative incretin pharmacology

Head-to-head studies in preclinical models have compared ORP-2(TR) to ORP-1(SM) and other GLP-1R selective agonists to characterize the added contribution of GIPR co-activation to metabolic outcomes and receptor-level signaling differences.

Methodology

How ORP-2(TR) is studied

  1. 01Method 1In cell-based assays, ORP-2(TR) is applied to GLP-1R- or GIPR-expressing cell lines at picomolar to nanomolar concentrations.+

    In cell-based assays, ORP-2(TR) is applied to GLP-1R- or GIPR-expressing cell lines at picomolar to nanomolar concentrations. Researchers measure cAMP accumulation using HTRF or ELISA-based assays, cell-surface receptor expression by flow cytometry, and downstream phosphorylation events by immunoblot to construct mechanistic pharmacology profiles.

  2. 02Method 2Preclinical mouse and rat models of diet-induced obesity and type 2 diabetes have been used to study ORP-2(TR)'s effects on fasting and postprandial glucose,…+

    Preclinical mouse and rat models of diet-induced obesity and type 2 diabetes have been used to study ORP-2(TR)'s effects on fasting and postprandial glucose, HbA1c-equivalent endpoints, body weight, adiposity, and liver steatosis markers. These studies often include pair-feeding controls and receptor-selective agonist comparators to dissect GLP-1R versus GIPR contributions.

  3. 03Method 3Pharmacokinetic studies characterize ORP-2(TR)'s plasma half-life, albumin binding fraction, volume of distribution, and metabolite profile.+

    Pharmacokinetic studies characterize ORP-2(TR)'s plasma half-life, albumin binding fraction, volume of distribution, and metabolite profile. Mass spectrometry-based methods are used to quantify intact ORP-2(TR) and its degradation products in plasma samples from preclinical models, informing experimental protocol design.

Storage protocols

ORP-2(TR) storage and handling

Full handling protocol+

Store lyophilized ORP-2(TR) at -20 C or below, protected from light and humidity. The lyophilized form is stable for extended periods under these conditions. Reconstitute in sterile saline or bacteriostatic water using aseptic technique. Store reconstituted solutions at 4 C for short-term use or aliquot and freeze at -80 C to minimize degradation. Avoid repeated freeze-thaw cycles, which can promote peptide aggregation and loss of activity. The fatty diacid-modified structure of ORP-2(TR) should be considered when selecting reconstitution buffers to ensure full solubilization. Maintain full chain-of-custody documentation per laboratory protocol.

Ordering & shipping

Buy ORP-2(TR) online

ORP-2(TR) for sale from Optimum ReGen Peptides, a US research-peptide company with a storefront in Medford, Oregon. It is in stock, priced from $150. Every order ships 2-Day Priority Air, a $13 flat rate anywhere in the US, with tracking, or can be picked up at the store.

The current batch has a published third-party certificate of analysis, shown above. ORP-2(TR) is supplied as lyophilized powder, for laboratory and research use only, not for human consumption.

FAQ

ORP-2(TR) FAQ

What makes ORP-2(TR) a 'dual agonist' compared to ORP-1(SM)?
ORP-1(SM) acts selectively at GLP-1R. ORP-2(TR) was designed to co-activate both GLP-1R and GIPR simultaneously within a single molecule. Research has investigated whether this dual receptor engagement produces additive or synergistic effects on metabolic endpoints compared to GLP-1R monoagonism.
What is the role of GIPR in metabolic research?
GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone secreted by K-cells of the small intestine in response to nutrient ingestion. GIPR is expressed on pancreatic beta-cells, adipocytes, and central neurons. Research continues to characterize exactly how GIPR activation contributes to the metabolic effects observed with ORP-2(TR).
How is ORP-2(TR)'s half-life extended?
ORP-2(TR) contains a C20 fatty diacid modification conjugated via a hydrophilic linker to lysine-26. This enables reversible albumin binding in plasma, protecting the peptide from renal filtration and proteolytic degradation and extending its half-life to approximately five days.
Is ORP-2(TR) sequence related to native GLP-1 or GIP?
ORP-2(TR)'s 39-residue sequence incorporates elements that enable binding to both GLP-1R and GIPR, but it is not identical to either native peptide. Specific residues are substituted at key positions to enable GIPR activity while retaining GLP-1R engagement.
What preclinical models have been used to study ORP-2(TR)?
Diet-induced obesity (DIO) mouse models, db/db mice, and Zucker diabetic fatty rats have been used in published research. These models allow researchers to study metabolic outcomes in contexts of established obesity and insulin resistance, providing a relevant framework for investigating dual incretin receptor pharmacology.
Research library

ORP-2(TR) research guides

Optimum ReGen Peptides
Optimum ReGen Peptides

Optimum ReGen Peptides provides high-quality peptide compounds for laboratory research applications. All research products, including all peptides, are strictly for research purposes only and are not intended for human consumption.

Research products are intended for laboratory research purposes only. Not for human consumption. Our tallow skincare products are topical cosmetics for external use only. No product is intended to diagnose, treat, cure, or prevent any disease.

Get new drops & restocks

New compounds, restock alerts, and updates from a real US lab. Research use only.

Payment options are checked at checkout

© 2026 Optimum ReGen Peptides. All rights reserved.
Engineered for Consistency. Built for Research.